Literature DB >> 30472293

Faecal microbiota transplantation shortens the colonisation period and allows re-entry of patients carrying carbapenamase-producing bacteria into medical care facilities.

Nadia Saïdani1, Jean-Christophe Lagier2, Nadim Cassir1, Matthieu Million3, Sophie Baron4, Grégory Dubourg3, Carole Eldin3, Jad Kerbaj1, Camille Valles5, Didier Raoult3, Philippe Brouqui3.   

Abstract

BACKGROUND: Colonisation with carbapenemase-producing Enterobacteriaceae or Acinetobacter (CPE/A) is associated with complex medical care requiring implementation of specific isolation policies and limitation of patient discharge to other medical facilities. Faecal microbiota transplantation (FMT) has been proposed in order to reduce the duration of gut colonisation.
OBJECTIVES: This study investigated whether a dedicated protocol of FMT could reduce the negativation time of CPE/A intestinal carriage in patients whose medical care has been delayed due to such colonisation.
METHOD: A matched case-control retrospective study between patients who received FMT treatment and those who did not among CPE/A-colonised patients addressed for initial clustering at the current institute. The study adjusted two controls per case based on sex, age, bacterial species, and carbapenemase type. The primary outcome was delay in negativation of rectal-swab cultures.
RESULTS: At day 14 post FMT, 8/10 (80%) treated patients were cleared for intestinal CPE/A carriage. In the control group, 2/20 (10%) had spontaneous clearance at day 14 after CPE/A diagnosis. Faecal microbiota transplantation led patients to reduce the delay in decolonisation (median 3 days post FMT for treated patients vs. 50.5 days after the first documentation of digestive carriage for control patients) and discharge from hospital (median 19.5 days post FMT for treated patients vs. 41 for control patients).
CONCLUSION: Faecal microbiota transplantation is a safe and time-saving procedure to discharge CPE/A-colonised patients from the hospital. A standardised protocol, including 5 days of antibiotic treatment, bowel cleansing and systematic indwelling devices removal, should improve protocol effectiveness.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Carbapenem-resistant Enterobacteriaceae; Decolonisation; Faecal microbiota transplantation; Multidrug-resistant bacteriae

Mesh:

Substances:

Year:  2018        PMID: 30472293     DOI: 10.1016/j.ijantimicag.2018.11.014

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  13 in total

1.  The Role of Microbiota in Preventing Multidrug-Resistant Bacterial Infections.

Authors:  Yascha Khodamoradi; Johanna Kessel; Jörg Janne Vehreschild; Maria J G T Vehreschild
Journal:  Dtsch Arztebl Int       Date:  2019-10-04       Impact factor: 5.594

Review 2.  Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future Perspectives.

Authors:  Livia Gargiullo; Federica Del Chierico; Patrizia D'Argenio; Lorenza Putignani
Journal:  Front Microbiol       Date:  2019-07-25       Impact factor: 5.640

3.  Extensive culturomics of 8 healthy samples enhances metagenomics efficiency.

Authors:  Ami Diakite; Grégory Dubourg; Niokhor Dione; Pamela Afouda; Sara Bellali; Issa Isaac Ngom; Camille Valles; Matthieu Million; Anthony Levasseur; Frédéric Cadoret; Jean-Christophe Lagier; Didier Raoult
Journal:  PLoS One       Date:  2019-10-21       Impact factor: 3.240

Review 4.  Bacterial, Gut Microbiome-Modifying Therapies to Defend against Multidrug Resistant Organisms.

Authors:  Amy Feehan; Julia Garcia-Diaz
Journal:  Microorganisms       Date:  2020-01-24

5.  Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis.

Authors:  Jessica Emily Green; Jessica A Davis; Michael Berk; Christopher Hair; Amy Loughman; David Castle; Eugene Athan; Andrew A Nierenberg; John F Cryan; Felice Jacka; Wolfgang Marx
Journal:  Gut Microbes       Date:  2020-11-09

6.  Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.

Authors:  Fengqin Su; Yi Luo; Jian Yu; Jimin Shi; Yanmin Zhao; Mengni Yan; He Huang; Yamin Tan
Journal:  Eur J Med Res       Date:  2021-04-28       Impact factor: 2.175

7.  Effect of a Multispecies Probiotic on Intestinal and Skin Colonization by Multidrug-Resistant Gram-Negative Bacteria in Patients in a Long-Term Care Facility: A Pilot Study.

Authors:  Ines Zollner-Schwetz; Monika Scarpatetti; Gerald Pichler; Christian Pux; Ingeborg Klymiuk; Slave Trajanoski; Robert Krause
Journal:  Nutrients       Date:  2020-05-28       Impact factor: 5.717

Review 8.  The Intestinal Microbiota as a Reservoir and a Therapeutic Target to Fight Multi-Drug-Resistant Bacteria: A Narrative Review of the Literature.

Authors:  Andrea Aira; Csaba Fehér; Elisa Rubio; Alex Soriano
Journal:  Infect Dis Ther       Date:  2019-10-25

Review 9.  Gut Microbiota Modulation: Implications for Infection Control and Antimicrobial Stewardship.

Authors:  Glorijoy Shi En Tan; Hui Lin Tay; Sock Hoon Tan; Tau Hong Lee; Tat Ming Ng; David Chien Lye
Journal:  Adv Ther       Date:  2020-08-07       Impact factor: 3.845

10.  Is there a role of faecal microbiota transplantation in reducing antibiotic resistance burden in gut? A systematic review and Meta-analysis.

Authors:  Priyanga Dharmaratne; Nannur Rahman; Anthony Leung; Margaret Ip
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.